Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Freedman, Mark S
CALLIPER, NCT05054140 / 2021-000048-23: Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis	Active, not recruiting	2	450	Europe, Canada, US, RoW	IMU-838, Vidofludimus calcium, Placebo matching IMU-838, Placebo Arm	Immunic AG	Multiple Sclerosis	01/25	01/25
PAT-MS, NCT04267185: A Dyadic Approach for Promoting Physical Activity Among People with MS and Their Support Partners	Completed	N/A	22	Canada	Physical Activity Together for PwMS and their CGs (PAT-MS)	University of Ottawa, The Ottawa Hospital, Consortium of Multiple Sclerosis Centers, Queen's University	Multiple Sclerosis	06/22	10/22
MS-DETECT, NCT05816122: Early Detection of Multiple Sclerosis Progression with MSCopilot® Detect	Recruiting	N/A	314	Europe, Canada, US	MSCopilot® Detect mobile application	Ad scientiam	Multiple Sclerosis	12/26	12/26
Freedman, Carol
No trials found